Plain-English translation of NCT06668454 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The TORO trial is testing a treatment approach for people with esophageal or stomach cancer that has spread to a limited number of places in the body. You would receive chemotherapy combined with immunotherapy (drugs that help your immune system fight cancer) before undergoing surgery to remove the primary tumor and any metastatic sites. This combination approach is showing promise in early studies, with some patients living significantly longer than expected.
Esophageal and stomach cancer that has spread to other parts of the body typically has a poor outlook. However, recent research suggests that when cancer has spread to only a few locations (called oligometastatic disease), combining the new immunotherapy drugs with traditional chemotherapy and then surgery may give patients a better chance at longer survival than treatments alone.
You likely qualify if…
You likely don't qualify if…
You would receive chemotherapy and immunotherapy treatment first (typically over several months), followed by surgery to remove your primary tumor and any metastatic sites. Throughout the trial, you would have regular clinic visits for blood tests, imaging scans, and check-ups to monitor how you are responding to treatment and for any side effects. After surgery, you would continue to be followed by the research team with periodic visits and scans to see how well the treatment worked and whether your cancer returns.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Canada